Table 3

Financial conflicts of interest among clinicians consulted on drug funding decisions

CharacteristicSubmissions (n=342)
Clinician submissions declaring conflicts228 (67)
Clinician submissions with conflicts with the manufacturer of the drug under review149 (44)
Average number of conflicts per submission (IQR)3 (2–6)
Types of conflicts reported
 Advisory role166 (51)
 Honoraria74 (23)
 Conference22 (7)
 Research22 (7)
 Events23 (7)
 Operations2 (1)
 Travel3 (1)
 Speaking12 (1)
Incomplete conflict of interest documentation9 (3)